(1.20%) 5 070.55 points
(0.69%) 38 504 points
(1.59%) 15 697 points
(0.11%) $83.45
(1.21%) $1.834
(-0.24%) $2 336.50
(-0.19%) $27.31
(-0.31%) $919.90
(0.02%) $0.934
(-0.03%) $10.90
(0.01%) $0.803
(0.01%) $93.20
@ $0.320
Issued: 12 Feb 2024 @ 15:54
Return: 0.25%
Previous signal: Feb 8 - 13:16
Previous signal:
Return: -39.64 %
Live Chart Being Loaded With Signals
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI)...
Stats | |
---|---|
Today's Volume | 1.61M |
Average Volume | 3.77M |
Market Cap | 995 918 |
EPS | $0 ( 2024-02-14 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0978 |
ATR14 | $0.132 (50.77%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-02-05 | Foose Brice | Sell | 37 000 | InVivo Therapeutics Holdings Corp |
2023-02-05 | Foose Brice | Sell | 20 000 | InVivo Therapeutics Holdings Corp |
2023-02-05 | Foose Brice | Sell | 13 000 | InVivo Therapeutics Holdings Corp |
2023-02-05 | Foose Brice | Sell | 48 000 | InVivo Therapeutics Holdings Corp |
2023-02-05 | Foose Brice | Sell | 12 000 | InVivo Therapeutics Holdings Corp |
INSIDER POWER |
---|
-77.03 |
Last 96 transactions |
Buy: 1 863 376 | Sell: 980 837 |
Volume Correlation
InVivo Therapeutics Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
InVivo Therapeutics Correlation - Currency/Commodity
InVivo Therapeutics Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $-445 000 (0.00 %) |
EPS: | $-6.62 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-72 000.00 (0.00 %) |
EPS: | $-0.870 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-111 000 (0.00 %) |
EPS: | $-0.620 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-119 000 (0.00 %) |
EPS: | $-0.800 |
Financial Reports:
No articles found.
InVivo Therapeutics
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators